Aneurysmal subarachnoid hemorrhage (aSAH) is a medical emergency that accounts for
5% of all stroke cases. Individuals affected are typically in the prime of their lives (mean age …

Aneurysmal subarachnoid hemorrhage (SAH) is a worldwide health burden with high fatality
and permanent disability rates. The overall prognosis depends on the volume of the initial …

Despite improvements in the clinical management of aneurysmal subarachnoid
haemorrhage over the last decade, delayed cerebral ischaemia (DCI) remains the single …

Pathophysiological processes following subarachnoid hemorrhage (SAH) present survivors
of the initial bleeding with a high risk of morbidity and mortality during the course of the …

Subarachnoid hemorrhage (SAH) is an important cause of stroke mortality and morbidity,
especially in the young stroke population. Recent evidences indicate that neuroinflammation …

The current literature provides a body of evidence on C-Reactive Protein (CRP) and its
potential role in inflammation. However, most pieces of evidence are sparse and …

Background and Purpose: Outcome prediction after aneurysmal subarachnoid hemorrhage
(aSAH) is challenging. CRP (C-reactive protein) has been reported to be associated with …

Background Acute brain injuries are associated with high mortality rates and poor long-term
functional outcomes. Measurement of cerebrospinal fluid (CSF) biomarkers in patients with …

Delayed cerebral vasospasm has classically been considered the most important and
treatable cause of mortality and morbidity in patients with aneurysmal subarachnoid …

Objective: Cerebral vasospasm is associated with poor prognosis in patients with
aneurysmal subarachnoid hemorrhage (SAH), and biomarkers for predicting poor prognosis …